Amid another call for separate medication rules for Thoroughbreds and Standardbreds, the Ohio State Racing Commission (OSRC) has indicated it’s not prepared to adopt a uniform national drug policy.

The United States Trotting Association (USTA) in late September dropped out of the Racing Medication and Testing Consortium (RMTC) and also publicly rejected the proposed national model rules on medication developed by the RMTC and passed by the Association of Racing Commissioners International. On Dec. 6 USTA president Phil Langley claimed the RMTC didn’t accurately describe the USTA’s position.

The RMTC recently issued a release stating there is no physiologic difference between breeds to warrant separate rules. 

In a letter to RMTC chairman Alex Waldrop, Langley said the RMTC at a September meeting knew the USTA had requested to continue using the bronchodilator clenbuterol and corticosteroids as the harness industry has for years

Create a free account with TheHorse.com to view this content.

TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com.

Start your free account today!

Already have an account?
and continue reading.